ID

12423

Description

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02106988

Link

https://clinicaltrials.gov/show/NCT02106988

Keywords

Versions (1)
  1. 11/17/15 11/17/15 -
Uploaded on

November 17, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT02106988

English

Eligibility Lymphoma NCT02106988

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02106988
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with newly diagnosed stage i and ii nasal nk cell lymphoma.
Description

Nasal nk cell lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0392788
2. adequate blood cell counts (i.e. anc > 1000) at baseline, or willingness to accept supportive measures such as transfusions, filgrastim, and epoetin.
Description

Adequate blood cell count

Data type

boolean

Alias
UMLS CUI [1]
C0005771
UMLS CUI [2]
C1879316
3. patients must have adequate liver function as indicated by: *bilirubin </= 1.5 times the upper limit of normal (uln), * alanine transaminase (alt) </= 2 times the (uln) or aspartate transaminase (ast) </= 2 times the uln, *these values must be obtained within two weeks before protocol entry.
Description

Adequate liver function

Data type

boolean

Alias
UMLS CUI [1]
C0232741
4. patients are required to have a serum creatinine </= 2.0 mg/dl. this value must be obtained within two weeks before protocol entry.
Description

Serum creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0600061
5. left ventricular ejection fraction must be evaluated by nuclear medicine scan or echocardiography and measure >/= 50%.
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
6. male patients must agree to use a barrier method of contraception or agree to abstain from heterosexual activity for the duration of the study.
Description

Barrier method of contraception

Data type

boolean

Alias
UMLS CUI [1]
C0004764
UMLS CUI [2]
C3840693
7. female patients must be willing to use two adequate barrier methods of contraception to prevent pregnancy or agree to abstain from heterosexual activity throughout the study or be post menopausal (free from menses > two years or surgically sterilized).
Description

Barrier methods of contraception

Data type

boolean

Alias
UMLS CUI [1]
C3840693
UMLS CUI [2]
C0558251
8. female patients of childbearing potential must have a negative serum pregnancy test (bhcg) within 2 weeks of protocol entry.
Description

Negative serum pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0430061
9. patients must have the ability to give informed consent.
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with active hepatitis b and/or hepatitis c infection.
Description

Hepatitis B and hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C2711110
2. patients with active infections requiring specific anti-infective therapy are not eligible until all signs of infections are resolved.
Description

Anti-infective therapy

Data type

boolean

Alias
UMLS CUI [1]
C1141958
3. patients known to be hiv positive.
Description

Hiv positive

Data type

boolean

Alias
UMLS CUI [1]
C0019699
4. patients with pre-existing cardiovascular disease requiring ongoing treatment. this includes: a) congestive heart failure class iii/iv chf per new york heart association (nyha) criteria. b) cardiomyopathy, c) uncontrolled cardiac arrhythmia, d) unstable angina pectoris, e) recent mi (within 6 months).
Description

Cardiovascular Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0007222
5. patients who are pregnant or breast-feeding.
Description

Pregnant or breast-feeding

Data type

boolean

Alias
UMLS CUI [1]
C3242212
6. patients with psychiatric illness and/or social situations that would limit compliance with the study medication and requirements.
Description

Mental disorders

Data type

boolean

Alias
UMLS CUI [1]
C0004936
UMLS CUI [2]
C1709261
7. prior radiation to the site of current primary disease, if re-treatment would lead to violation of known radiation dose tolerance limits for that site.
Description

Prior radiation

Data type

boolean

Alias
UMLS CUI [1]
C1522449
Back to the top of the page

Similar models

Eligibility Lymphoma NCT02106988

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02106988
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Nasal nk cell lymphoma
Item
1. patients with newly diagnosed stage i and ii nasal nk cell lymphoma.
boolean
C0392788 (UMLS CUI [1])
Adequate blood cell count
Item
2. adequate blood cell counts (i.e. anc > 1000) at baseline, or willingness to accept supportive measures such as transfusions, filgrastim, and epoetin.
boolean
C0005771 (UMLS CUI [1])
C1879316 (UMLS CUI [2])
Adequate liver function
Item
3. patients must have adequate liver function as indicated by: *bilirubin </= 1.5 times the upper limit of normal (uln), * alanine transaminase (alt) </= 2 times the (uln) or aspartate transaminase (ast) </= 2 times the uln, *these values must be obtained within two weeks before protocol entry.
boolean
C0232741 (UMLS CUI [1])
Serum creatinine
Item
4. patients are required to have a serum creatinine </= 2.0 mg/dl. this value must be obtained within two weeks before protocol entry.
boolean
C0600061 (UMLS CUI [1])
Left ventricular ejection fraction
Item
5. left ventricular ejection fraction must be evaluated by nuclear medicine scan or echocardiography and measure >/= 50%.
boolean
C0428772 (UMLS CUI [1])
Barrier method of contraception
Item
6. male patients must agree to use a barrier method of contraception or agree to abstain from heterosexual activity for the duration of the study.
boolean
C0004764 (UMLS CUI [1])
C3840693 (UMLS CUI [2])
Barrier methods of contraception
Item
7. female patients must be willing to use two adequate barrier methods of contraception to prevent pregnancy or agree to abstain from heterosexual activity throughout the study or be post menopausal (free from menses > two years or surgically sterilized).
boolean
C3840693 (UMLS CUI [1])
C0558251 (UMLS CUI [2])
Negative serum pregnancy test
Item
8. female patients of childbearing potential must have a negative serum pregnancy test (bhcg) within 2 weeks of protocol entry.
boolean
C0430061 (UMLS CUI [1])
Informed consent
Item
9. patients must have the ability to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hepatitis B and hepatitis C
Item
1. patients with active hepatitis b and/or hepatitis c infection.
boolean
C2711110 (UMLS CUI [1])
Anti-infective therapy
Item
2. patients with active infections requiring specific anti-infective therapy are not eligible until all signs of infections are resolved.
boolean
C1141958 (UMLS CUI [1])
Hiv positive
Item
3. patients known to be hiv positive.
boolean
C0019699 (UMLS CUI [1])
Cardiovascular Diseases
Item
4. patients with pre-existing cardiovascular disease requiring ongoing treatment. this includes: a) congestive heart failure class iii/iv chf per new york heart association (nyha) criteria. b) cardiomyopathy, c) uncontrolled cardiac arrhythmia, d) unstable angina pectoris, e) recent mi (within 6 months).
boolean
C0007222 (UMLS CUI [1])
Pregnant or breast-feeding
Item
5. patients who are pregnant or breast-feeding.
boolean
C3242212 (UMLS CUI [1])
Mental disorders
Item
6. patients with psychiatric illness and/or social situations that would limit compliance with the study medication and requirements.
boolean
C0004936 (UMLS CUI [1])
C1709261 (UMLS CUI [2])
Prior radiation
Item
7. prior radiation to the site of current primary disease, if re-treatment would lead to violation of known radiation dose tolerance limits for that site.
boolean
C1522449 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial